Trial Profile
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Povidone iodine/dexamethasone (Primary) ; Povidone iodine
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Registrational; Therapeutic Use
- Sponsors Shire
- 12 Nov 2018 Status changed from recruiting to completed.
- 24 Sep 2018 Planned End Date changed from 1 Mar 2018 to 31 Oct 2018.
- 24 Sep 2018 Planned primary completion date changed from 1 Mar 2018 to 31 Oct 2018.